Skip to content
Search

Latest Stories

Research raises concerns about impact of Ramadan fasting on diabetics during lockdown

Lack of physical activity and poor sleep patterns during Ramadan can affect the health of people with Type 2 diabetes, a latest study has shown.

A research by De Montfort University Leicester has also raised concern that the coronavirus lockdown could lead to a dramatic fall in physical activity compared to previous Ramadan festivals.


The patients with Type 2 diabetes should seek medical advice as to whether they take part or not in the Ramadan fasting, the experts have opined.

Dr Abdullah Alghamdi and Professor Parvez Haris have found that lack of physical activity and small periods of night time sleep during Ramadan can affect the way the body uses insulin and glucose.

Dr Alghamdi, under the guidance of Haris, carried out the study in Saudi Arabia on 16 women and 20 men with type-two diabetes.

The research concluded that “the low physical activity and the poor sleep behaviours of the study’s participants may worsen their diabetes” and furthermore this could “minimise the potential of Ramadan intermittent fasting as a non-pharmacological therapy” for managing or even reversing Type 2 diabetes.

Dr Alghamdi said anyone with Type 2 diabetes should seek medical advice about whether they can take part in the fasting.

The researchers have concluded that previously published research had shown intermittent fasting can benefit the health of Type 2 diabetics – but a total lack of physical activity could negate this.

More For You

national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less